From: A decade of investments in monitoring the HIV epidemic: how far have we come? A descriptive analysis
 |  | 2006 | 2008 | 2010 | |||
---|---|---|---|---|---|---|---|
 |  | N1 | %2 | N1 | %2 | N1 | %2 |
 |  |  | (95% CI) |  | (95% CI) |  | (95% CI) |
HIV M&E system performance | |||||||
Population-based indicator stream | High-burden LMICs | 11 | 50% | 20 | 91% | 21 | 95% |
(29–71) | (79–100) | (87–100) | |||||
Other LMICs | 11 | 20% | 53 | 95% | 47 | 84% | |
(3–36) | (85–100) | (69–99) | |||||
Key population indicator stream | High-burden LMICs | 5 | 23% | 15 | 68% | 16 | 73% |
(5–40) | (49–88) | (54–91) | |||||
Other LMICs | 28 | 50% | 45 | 80% | 46 | 82% | |
(29–71) | (64–97) | (66–98) | |||||
Service delivery indicator stream | High-burden LMICs | 18 | 82% | 22 | 100% | 22 | 100% |
(66–98) | |||||||
Other LMICs | 23 | 41% | 56 | 100% | 56 | 100% | |
(21–62) | |||||||
Sex disaggregated data on antiretroviral therapy3 | High-burden LMICs | 18 | 82% | – | – | 19 | 86% |
(66–98) | (72–100) | ||||||
Other LMICs | 35 | 63% | – | – | 44 | 79% | |
(42–83) | (61–96) | ||||||
HIV M&E performance score | High-burden LMICs | 11 | 52% | 19 | 86% | 20 | 89% |
(34–69) | (73–100) | (77–100) | |||||
Other LMICs | 21 | 37% | 51 | 92% | 50 | 89% | |
 |  |  | (17–57) |  | (81–100) |  | (75–100) |